Page last updated: 2024-08-24

plerixafor and Plasma Cell Tumor

plerixafor has been researched along with Plasma Cell Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ansell, SM; Buadi, F; Dingli, D; Dispenzieri, A; Gastineau, DA; Gertz, MA; Hayman, SR; Hogan, WJ; Inwards, DJ; Johnston, PB; Kumar, S; Lacy, MQ; Litzow, MR; Micallef, IN; Porrata, LF; Sinha, S; Winters, JL; Wolf, R	1

Trials

1 trial(s) available for plerixafor and Plasma Cell Tumor

Article	Year
Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013, Volume: 19, Issue:1 Topics: Adult; Aged; Algorithms; Benzylamines; Case-Control Studies; Costs and Cost Analysis; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Plasmacytoma; Risk Factors; Time Factors; Transplantation, Autologous	2013

Article

Year

Cost-effectiveness analysis of a risk-adapted algorithm of plerixafor use for autologous peripheral blood stem cell mobilization.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2013, Volume: 19, Issue:1

Topics: Adult; Aged; Algorithms; Benzylamines; Case-Control Studies; Costs and Cost Analysis; Cyclams; Female; Hematopoietic Stem Cell Mobilization; Heterocyclic Compounds; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Plasmacytoma; Risk Factors; Time Factors; Transplantation, Autologous

2013